Evidence map›Paper›PMID 32523075›Full record

Trial reportScientific reports2020

Prediction of prostate cancer aggressiveness using

Parisa Movahedi, Harri Merisaari, Ileana Montoya Perez, Pekka Taimen, Jukka Kemppainen, Anna Kuisma, Olli Eskola, Jarmo Teuho, Jani Saunavaara, Marko Pesola and 8 more

Registry-linked trialAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02002455 (Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02002455 phase2completednot on this map

Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma

TypeinterventionalSponsorTurku University HospitalRan2013 to 2016Enrolled26ConditionsProstate CarcinomaArmsPET/CT, PET/MRI, mpMRI
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Radiology. Imaging cancer · 2022
    Pooled it
  2. Article
  3. Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Parisa MovahediDepartment of Future Technologies, University of Turku, Turku, Finland.
Harri MerisaariDepartment of Future Technologies, University of Turku, Turku, Finland.
Ileana Montoya PerezDepartment of Future Technologies, University of Turku, Turku, Finland.
Pekka TaimenInstitute of Biomedicine, University of Turku and Department of Pathology, Turku University, Hospital, Turku, Finland.
Jukka KemppainenTurku PET Centre, Turku University and Turku University Hospital, Turku, Finland.
Anna KuismaDepartment of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.
Olli EskolaTurku PET Centre, Turku University and Turku University Hospital, Turku, Finland.
Jarmo TeuhoTurku PET Centre, Turku University and Turku University Hospital, Turku, Finland.
Jani SaunavaaraDepartment of Medical Physics, Turku University Hospital, Turku, Finland.
Marko PesolaDepartment of Diagnostic Radiology, University of Turku, Turku, Finland.
Esa KähkönenDepartment of Urology, University of Turku and Turku University hospital, Turku, Finland.
Otto EttalaDepartment of Urology, University of Turku and Turku University hospital, Turku, Finland.
Timo LiimatainenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Tapio PahikkalaDepartment of Future Technologies, University of Turku, Turku, Finland.
Peter BoströmDepartment of Urology, University of Turku and Turku University hospital, Turku, Finland.
Hannu AronenDepartment of Diagnostic Radiology, University of Turku, Turku, Finland.
Heikki MinnTurku PET Centre, Turku University and Turku University Hospital, Turku, Finland.
Ivan JamborDepartment of Diagnostic Radiology, University of Turku, Turku, Finland. ivjamb@utu.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this prospective single-institution clinical trial (NCT02002455) was to evaluate the potential of advanced post-processing methods for

Indexed as

Carboxylic AcidsCyclobutanesHumansMaleMultiparametric Magnetic Resonance ImagingNeoplasm GradingPositron Emission Tomography Computed TomographyProspective StudiesProstateProstatectomyProstatic NeoplasmsRadiopharmaceuticalsCarboxylic AcidsCyclobutanesfluciclovine F-18Radiopharmaceuticals

Identifiers

PMID32523075
PMCPMC7287051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.